Study finds microplastics in most prostate tumors

Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds.  The small, single-center study was led by researchers at NYU Langone Health, its Perlmutter Cancer Center, and its Center for the Investigation of Environmental Hazards. … Read more

What actually happens in a prostate cancer screening?

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less. To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, we spoke with Mr Wissam Abou-Chedid, consultant urological and robotic surgeon at Nuffield Health in Woking, Guildford, and Parkside in London, who helped … Read more

Tiny organism offers insight into neurological side effects of chemotherapy

Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant long-term side effects that can dramatically affect patients’ quality of life. Among the most debilitating is Chemotherapy-Induced Peripheral Neuropathy, which impacts both the central and peripheral nervous systems and affects up to 85% of cancer patients … Read more

Prostate Cancer Overtakes Lung Cancer as Most Common in South Korean Men – 조선일보

Prostate Cancer Overtakes Lung Cancer as Most Common in South Korean Men  조선일보 Source link

Lifetime heavy drinking sharply raises colorectal cancer risk, major US study finds

A large US trial shows that the cumulative burden of alcohol over decades matters for colorectal cancer risk, with heavy lifelong drinking increasing danger and stopping alcohol linked to fewer early precancerous polyps. Study: Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian … Read more

Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether combining precision radiation with a targeted radioactive therapy drug can help patients with recurrent prostate cancer delay progression, while delaying or avoiding the side effects of long-term hormone therapy. The Phase 2 trial, called ANDROMEDA, is the first study to … Read more

Key findings from 2026 report

New national estimates reveal historic gains in cancer survival and millions of deaths averted, while exposing stark inequities and warning that policy decisions today could determine whether progress continues or stalls. Study: Cancer statistics, 2026. Image credit: Yuganov Konstantin/Shutterstock.com The American Cancer Society (ACS) has published the 2026 cancer statistics in CA: A Cancer Journal … Read more

Scientists develop AI method to predict overall survival rate of prostate cancer patients

Machine learning prediction of overall survival in prostate adenocarcinoma using ensemble techniques. Copyright: Computers in Biology and Medicine. Doi: https://doi.org/10.1016/j.compbiomed.2025.110008 The dataset on prostate adenocarcinoma on an ensemble ML model for the prediction of the OS of PAC patients. The models are also evaluated based on the evaluation metrics. Copyright: Computers in Biology and Medicine. … Read more

New AI test identifies prostate cancer patients who benefit from abiraterone

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from UCL and the Institute of Cancer Research. The researchers analyzed prostate cancer tumour samples from men with high-risk prostate cancer that had not spread, who took … Read more

New trial offers hope for men with aggressive prostate cancer

Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment. A new Phase 2 clinical trial at UC Davis Comprehensive Cancer Center unveiled clues as to why these patients are doing poorly and may offer hope in the form of targeted therapy. The findings will be presented at the annual … Read more